Academic Journal
Q1Value in Health
About Value in Health
Value in Health is a scholarly journal published by Elsevier Ltd. SCImago 2025 places it in Q1 with an SJR of 1.626 and an H-index of 144.
Its listed coverage is 1998-2026 and its research categories include Health Policy (Q1); Medicine (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1). The 2025 dataset reports 259 documents and 2895 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Economic and Financial Impacts of Cancer, Medication Adherence and Compliance, Pharmaceutical studies and practices, Healthcare Policy and Management.
Recent Research Articles
Latest publications matched automatically by ISSN.
Do Quality-Adjusted-Life-Year-Based Cost-Effectiveness Analyses Discriminate Against Disabled Patients? A Theoretical and Empirical Analysis
Yue Ma, Peter J. Neumann, David J. Vanness, Hongchao Li et al.
2026-09 · DOI: 10.1016/j.jval.2026.04.005Cost-Effectiveness of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Aged 65 to 69 Years (CAREMM-2110 Study)
Jung Yeon Lee, Seungpil Jung, Sung-Soo Park, Seonggyu Byeon et al.
2026-09 · DOI: 10.1016/j.jval.2026.05.013Evaluating Policy Options for New Treatments Under Uncertain External Evidence
Yizhi Liang, Boshen Jiao
2026-09 · DOI: 10.1016/j.jval.2026.03.2240Table of Contents
2026-09 · DOI: 10.1016/s1098-3015(26)02575-1Impact of Smoothing and Modeling Approach on Quality-Adjusted Life Expectancy Estimates
Hosein Ameri, Thomas G. Poder
2026-09 · DOI: 10.1016/j.jval.2026.03.2241Understanding Preference Heterogeneity in Digital Neurorehabilitation: Results of a Discrete Choice Experiment
Ann-Kathrin Fischer, Andrew Sadler, Thomas Kohlmann, Axel Mühlbacher et al.
2026-09 · DOI: 10.1016/j.jval.2026.03.2238Author Reply
Ana Rita Santos, Francisco von Hafe, Filipa Sampaio, Ana Rita Londral et al.
2026-09 · DOI: 10.1016/j.jval.2026.04.015The Application of FDA Patient-Focused Drug Development Guidance in Rare Patient Populations: Innovation and Flexibility
Stacie Hudgens
2026-09 · DOI: 10.1016/j.jval.2026.09.001Validation and Clinical Meaningfulness of the 18-item National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Lymphoma Symptom Index in Patients With Lymphoma
Kimberly A. Webster, Anne R. Zola, Maria Corona, Elijah A. Patten et al.
2026-09 · DOI: 10.1016/j.jval.2026.03.2244Cost-Minimization Analysis of the Women’s Cancer Risk Identification—Quantitative Polymerase Chain Reaction Test for Endometrial Cancer Epigenetic Biomarker Compared With Transvaginal Ultrasound for Triaging Abnormal Uterine Bleeding
Tristan M. Snowsill, Sara Sleigh, James Barrett, Martin Widschwendter et al.
2026-09 · DOI: 10.1016/j.jval.2026.03.2235A Cost-Utility Analysis of LISTEN: Low-Intensity Mental Health Support via Telehealth-Enabled Network for Diabetes Distress
Joahna Kevin Perez, Mary Lou Chatterton, Harish Raj Narandaran, Matthew P. Hamilton et al.
2026-09 · DOI: 10.1016/j.jval.2026.03.2250Cost-Effectiveness of a Global Longitudinal Strain-Based Screening and Prevention Program for Pre-Heart Failure Compared With Standard of Care
Hannah Kentenich, Sebastian Kelle, Rebecca E. Beyer, Maximilian L. Müller et al.
2026-09 · DOI: 10.1016/j.jval.2026.04.002Assessing the Agreement Between Self- and Proxy-Reported Responses for Measuring Health-Related Quality of Life in People With Dementia Using the Alzheimer’s Disease 5 Dimensions Instrument
Syed A. Keramat, Tiet-Hanh Dao-Tran, Kim-Huong Nguyen, Alyssa Welch et al.
2026-09 · DOI: 10.1016/j.jval.2026.04.011Methodological Frameworks for Economic Evaluation of Digital Health Interventions
Carl Asche, Rossella Di Bidino, Anita Burrell, Annette Champion et al.
2026-09 · DOI: 10.1016/j.jval.2026.03.2252Beyond the Base Case: Payment Perspective and Ductal Carcinoma In Situ Management Assumptions in Artificial-Intelligence-Assisted Breast Screening Models
Runji Zhou, Jiayun Zou, Qiming Liu
2026-09 · DOI: 10.1016/j.jval.2026.03.2251Validity, Reliability, and Responsiveness of the EQ-5D in Hematological Cancers: A Systematic Review of Measurement Properties
Aleksandra Dudzisz, Grzegorz W. Basak, Emilian Snarski, Dominik Golicki et al.
2026-09 · DOI: 10.1016/j.jval.2026.03.2239Can Large Language Models Predict Patient Treatment Choices? A Discrete Choice Experiment Framework
Tina Cheng, Juan Marcos Gonzalez, Matthew M. Engelhard, Shelby D. Reed et al.
2026-09 · DOI: 10.1016/j.jval.2026.04.006Assessment of Carbon Emission Impact of Semaglutide in Patients With Type 2 Diabetes in the United Kingdom Using an Innovative Modeling Approach
Niels Lund, Andreas Rasche, Matthew Taylor, Barrie Chubb et al.
2026-09 · DOI: 10.1016/j.jval.2026.03.2249Paid and Unpaid Productivity Losses Associated With Musculoskeletal Conditions: Longitudinal Evidence From Australia
Nanati Legese Alemu, Anthony Niu, Jennifer J. Watts, Suzanne Robinson et al.
2026-09 · DOI: 10.1016/j.jval.2026.04.007Critical Comments by the European Medicines Agency on Patient-Reported Outcomes in Regulatory Submissions (2020 to 2023)
Courtney Levy, Sarah Sauchelli, Jessica L. Abel, Mia Wraight et al.
2026-09 · DOI: 10.1016/j.jval.2026.04.017Reviews
Community Reviews
Version History
September 7, 2026 at 11:59 pm
September 7, 2026